Electroconvulsive therapy (ECT) is an efficient and rapid-acting treatment indicated for severe depressive disorders. While ECT is commonly accompanied by transient memory decline, the brain mechanisms underlying these side effects remain unclear.
Aims:
In this exploratory functional magnetic resonance (fMRI) study, we aimed to compare effects of ECT versus pharmacological treatment on neural response during episodic memory encoding in patients with affective disorders.
Methods:
This study included 32 ECT-treated patients (major depressive disorder (MDD), n = 23; bipolar depression, n = 9) and 40 partially remitted patients in pharmacological treatment (MDD, n = 24; bipolar disorder, n = 16). Participants underwent neuropsychological assessment, a strategic picture encoding fMRI scan paradigm, and mood rating. The ECT group was assessed before ECT (pre-ECT) and 3 days after their eighth ECT session (post-ECT).
Results:
Groups were comparable on age, gender, and educational years (ps ⩾ 0.05). Within-group analyses revealed a selective reduction in verbal learning and episodic memory pre- to post-ECT (p = 0.012) but no decline in global cognitive performance (p = 0.3). Functional magnetic resonance imaging analyses adjusted for mood symptoms revealed greater activity in ECT-treated patients than pharmacologically treated No-ECT patients across left precentral gyrus (PCG), right dorsomedial prefrontal cortex (dmPFC), and left middle frontal gyrus (MFG). In ECT-treated patients, greater decline in verbal learning and memory performance from pre- to post-ECT correlated with higher PCG response (r = −0.46, p = 0.008), but not with dmPFC or MFG activity (ps ⩾ 0.1), post-ECT.
Conclusions:
Episodic memory decline was related to greater neural activity in the left PCG, but unrelated to increased dmPFC and MFG activity, immediately after ECT.
AbbottCCGallegosPRediskeN, et al (2014) A review of longitudinal electroconvulsive therapy: Neuroimaging investigations. J Geriatr Psychiatry Neurol27: 33–46.
2.
ArgyelanMLenczTKangS, et al (2021) ECT-induced cognitive side effects are associated with hippocampal enlargement. Transl Psychiatry11: 516.
3.
BaiTWeiQZuM, et al (2019) Functional plasticity of the dorsomedial prefrontal cortex in depression reorganized by electroconvulsive therapy: Validation in two independent samples. Hum Brain Mapp40: 465–473.
4.
BaldingerPLotanAFreyR, et al (2014) Neurotransmitters and electroconvulsive therapy. J ECT30: 116–121.
BauerJHagemanIDamH, et al (2009). Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: A randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT25: 85–90.
7.
BlombergMOSemkovskaMKesslerU, et al (2020) A longitudinal comparison between depressed patients receiving electroconvulsive therapy and healthy controls on specific memory functions. The Primary Care Companion for CNS Disorders22: 25482.
8.
BolwigTG (2014) Neuroimaging and electroconvulsive therapy: A review. J ECT30: 138–142.
9.
BouckaertFSienaertPObbelsJ, et al (2014) ECT: Its brain enabling effects: A review of electroconvulsive therapy–induced structural brain plasticity. J ECT30: 143–151.
10.
BrandtCLEicheleTMelleI, et al (2014). Working memory networks and activation patterns in schizophrenia and bipolar disorder: Comparison with healthy controls. Br J Psychiatry204: 290–298.
11.
BresslerSLMenonV (2010) Large-scale brain networks in cognition: Emerging methods and principles. Trends Cogn Sci14: 277–290.
12.
DesikanRSSégonneFFischlB, et al. (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage31: 968–980.
13.
DiasVVBalanzá-MartinezVSoeiro-de-SouzaM, et al (2012) Pharmacological approaches in bipolar disorders and the impact on cognition: A critical overview. Acta Psychiatr Scand126: 315–331.
14.
DickersonBCEichenbaumH (2010) The episodic memory system: Neurocircuitry and disorders. Neuropsychopharmacology35: 86–104.
15.
DumanRSMonteggiaLM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry59: 1116–1127.
16.
EmchMvon BastianCCKochK (2019) Neural correlates of verbal working memory: An fMRI meta-analysis. Front Hum Neurosci13: 180.
17.
FinkMKellnerCHMcCallWV (2014) The role of ECT in suicide prevention. J ECT30: 5–9.
18.
FonsekaTMMacQueenGMKennedySH (2018) Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. J Affect Disord233: 21–35.
19.
FranklandPWKöhlerSJosselynSA (2013) Hippocampal neurogenesis and forgetting. Trends Neurosci36: 497–503.
20.
GbylKStøttrupMMMitta RaghavaJ, et al (2021) Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta Psychiatr Scand143: 238–252.
21.
GbylKVidebechP (2018) Electroconvulsive therapy increases brain volume in major depression: A systematic review and meta-analysis. Acta Psychiatr Scand138: 180–195.
22.
HagemanINielsenMWortweinG, et al (2008) Electroconvulsive stimulations prevent stress-induced morphological changes in the hippocampus. Stress11: 282–289.
23.
HaghighiMSalehiIErfaniP, et al (2013) Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J Psychiatr Res47: 908–915.
24.
HamiltonM (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry23: 56–62.
25.
HaririARGoldbergTEMattayVS, et al. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience23(17): 6690–6694.
26.
HartshorneJKMakovskiT (2019) The effect of working memory maintenance on long-term memory. Mem Cognit47: 749–763.
27.
HermidaAPGoldsteinFCLoringDW, et al (2020) ElectroConvulsive therapy Cognitive Assessment (ECCA) tool: A new instrument to monitor cognitive function in patients undergoing ECT. J Affect Disord269: 36–42.
28.
HusainMMRushAJFinkM, et al (2004) Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A Consortium for Research in ECT (CORE) report. J Clin Psychiatry65: 485–491.
29.
JenkinsonMBeckmannCBehrensT, et al (2012) FSL. Neuroimage [Internet] 2012; 62: 782–90.
30.
JorgensenAMagnussonPHansonLG, et al (2016) Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatr Scand133: 154–164.
31.
KellnerCH (2012) Electroconvulsive Therapy (ECT). Brain Stimulation in Psychiatry: ECT, DBS, TMS and Other Modalities. Cambridge: Cambridge University Press.
32.
KessingLVMunkholmKFaurholt-JepsenM, et al (2017) The bipolar illness onset study: Research protocol for the BIO cohort study. BMJ Open7: e015462.
33.
KohlerSJWilliamsNIStantonGB, et al (2011) Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months. Proc Natl Acad Sci USA108: 10326–10331.
34.
LandryMMorenoAPatryS, et al (2021) Current practices of electroconvulsive therapy in mental disorders: A systematic review and meta-analysis of short and long-term cognitive effects. J ECT37: 119–127.
35.
LecrubierYSheehanDVWeillerE, et al (1997) The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiatry12: 224–231.
36.
LiMYaoXSunL, et al (2020) Effects of electroconvulsive therapy on depression and its potential mechanism. Front Psychol11: 80.
37.
MacoveanuJMariegaardJPetersenJZ, et al (2023) Neural basis of memory impairments and relation to functional disability in fully or partially remitted patients with affective disorders. Prog Neuro-Psychopharmacol Biol Psychiatry125: 110767.
38.
MadsenTMTreschowABengzonJ, et al (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry47: 1043–1049.
39.
McClintockSMChoiJDengZD, et al (2014) Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT30: 165–176.
40.
MiskowiakKWMacoveanuJVinbergM, et al (2016) Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders. Acta Psychiatr Scand134: 249–259.
41.
MiskowiakKWPetersenCS (2019) Neuronal underpinnings of cognitive impairment and-improvement in mood disorders. CNS Spectrums24: 30–53.
42.
MiskowiakKWPetersenJZMacoveanuJ, et al. (2024). Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial. European Neuropsychopharmacology79: 38–48. https://doi.org/https://doi.org/10.1016/j.euroneuro.2023.12.004
43.
NeeDEBrownJWAskrenMK, et al (2013) A meta-analysis of executive components of working memory. Cerebral Cortex23: 264–282.
44.
NoblerMSOquendoMAKegelesLS, et al (2001) Decreased regional brain metabolism after ECT. Am J Psychiatry158: 305–308.
45.
NoblerMSSackeimHA (2008) Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. J ECT24: 40–45.
46.
OttCVVinbergMKessingLV, et al (2021) Effect of action-based cognitive remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial. Bipolar Disorders23: 487–499.
47.
OusdalOTBrancatiGEKesslerU, et al (2022) The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: What have we learned, and where do we go?Biol Psychiatry91: 540–549.
48.
PetersenJZMacoveanuJKjaerstadHL, et al (2021) Assessment of the neuronal underpinnings of cognitive impairment in bipolar disorder with a picture encoding paradigm and methodological lessons learnt. J Psychopharmacol35: 983–991.
49.
PetersenJZSchmidtLSVinbergM, et al (2018) Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: A study protocol for a randomized controlled trial. Trials19: 611.
50.
PhanKLFitzgeraldDANathanPJ, et al (2005) Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging study. Biol Psychiatry57: 210–219.
51.
Porta-CasteràsDCanoMCamprodonJA, et al (2021) A multimetric systematic review of fMRI findings in patients with MDD receiving ECT. Prog Neuro-Psychopharmacol Biol Psychiatry108: 110178.
52.
PorterRJBauneBTMorrisG, et al (2020) Cognitive side-effects of electroconvulsive therapy: What are they, how to monitor them and what to tell patients. BJPsych Open6: e40.
53.
RoseDWykesTLeeseM, et al (2003) Patients’ perspectives on electroconvulsive therapy- systematic review. BMJ326: 1363.
54.
SackeimHA (2020) The impact of electroconvulsive therapy on brain grey matter volume: What does it mean?Brain Stimul13: 1226–1231.
55.
SackeimHAPrudicJFullerR, et al (2007) The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology32: 244–254.
56.
SchmidtLSPetersenJZVinbergM, et al (2018) Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: A study protocol for a randomized controlled trial. Trials19: 234.
57.
SchmidtM (1996) Rey Auditory Verbal Learning Test: RAVLT : a handbook. Los Angeles, CA: Western Psychological Services, p. 137.
58.
SemkovskaMMcLoughlinDM (2010) Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biol Psychiatry68: 568–577.
59.
ShapiroSSWilkMB (1965) An analysis of variance test for normality (complete samples). Biometrika52(3/4): 591–611.
60.
SwartzCM (2009) Stimulus electrode placement. In: SwartzCM (ed.) Electroconvulsive and Neuromodulation Therapies. Cambridge: Cambridge University Press, pp. 430–446.
61.
The UK ECT Review Group. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet361(9360): 799–808.
62.
van OostromIvan EijndhovenPButterbrodE, et al (2018) Decreased cognitive functioning after electroconvulsive therapy is related to increased hippocampal volume: Exploring the role of brain plasticity. J ECT34: 117–123.
63.
VasicNWalterHSambataroF, et al. (2009) Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing. Psychological Medicine39(6): 977–987. https://doi.org/10.1017/S0033291708004443
64.
VeitRLotzeMSewingS, et al. (2010) Aberrant social and cerebral responding in a competitive reaction time paradigm in criminal psychopaths. Neuroimage49: 3365–3372.
65.
VidebechPHjerrildSJorgensenA, et al (2020) ECT-vejledning 2020. Dansk Psykiatrisk Selskab.
66.
VietaE (2009) The influence of medications on neurocognition in bipolar disorder. Acta Psychiatr Scand120: 414–415.
67.
WagerTDSmithEE (2003) Neuroimaging studies of working memory. Cogn Affect Behav Neurosci3: 255–274.
68.
WalterHWolfRCSpitzerM, et al (2007) Increased left prefrontal activation in patients with unipolar depression: An event-related, parametric, performance-controlled fMRI study. J Affect Disord101: 175–185.
69.
WangDTianYLiM, et al (2020) Functional connectivity underpinnings of electroconvulsive therapy-induced memory impairments in patients with depression. Neuropsychopharmacology45: 1579–1587.
70.
WangX-LDuM-YChenT-L, et al (2015) Neural correlates during working memory processing in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry56: 101–108.
WoolrichMWBehrensTEBeckmannCF, et al (2004) Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage21: 1732–1747.
73.
WoolrichMWRipleyBDBradyM, et al (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage14: 1370–1386.
74.
WorsleyKJ (2001) Statistical analysis of activation images. Funct MRI14: 251–270.
75.
YoungRCBiggsJTZieglerVEMeyerDA. A Rating Scale for Mania: Reliability, Validity and Sensitivity. The British Journal of Psychiatry. 1978Nov;133(5):429–35.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
